Omada Health Management
Management criteria checks 3/4
Omada Health's CEO is Sean Duffy, appointed in Apr 2011, has a tenure of 14.67 years. total yearly compensation is $1.19M, comprised of 34.6% salary and 65.4% bonuses, including company stock and options. directly owns 1.5% of the company’s shares, worth €13.97M. The average tenure of the management team and the board of directors is 4 years and 1.5 years respectively.
Key information
Sean Duffy
Chief executive officer
US$1.2m
Total compensation
| CEO salary percentage | 34.65% |
| CEO tenure | 14.7yrs |
| CEO ownership | 1.5% |
| Management average tenure | 4yrs |
| Board average tenure | 1.5yrs |
Recent management updates
No updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2025 | n/a | n/a | -US$26m |
| Jun 30 2025 | n/a | n/a | -US$32m |
| Mar 31 2025 | n/a | n/a | -US$38m |
| Dec 31 2024 | US$1m | US$412k | -US$47m |
| Dec 31 2023 | US$1m | US$400k | -US$68m |
Compensation vs Market: Sean's total compensation ($USD1.19M) is about average for companies of similar size in the German market ($USD1.30M).
Compensation vs Earnings: Sean's compensation has been consistent with company performance over the past year.
CEO
Sean Duffy (41 yo)
Mr. Sean P. Duffy Co-founded Omada Health, Inc. in April 2011 and also serves as its Chief Executive Officer and Director since April 2011. Mr. Duffy worked for Google LLC from June 2007 to August 2009 and...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 14.7yrs | US$1.19m | 1.5% € 14.0m | |
| President | 4yrs | US$1.15m | 0.0044% € 40.8k | |
| Chief Financial Officer | 4.4yrs | US$838.32k | 0.0036% € 34.0k | |
| Chief Technology Officer | 3.8yrs | no data | no data | |
| Vice President of Investor Relations | no data | no data | no data | |
| General Counsel | no data | no data | no data | |
| Senior Vice President of Sales & Payer Access | no data | no data | no data | |
| Chief People Officer | 3.8yrs | no data | no data | |
| Chief Care Delivery Operating Officer | no data | no data | no data | |
| Chief Information Security Officer | no data | no data | no data | |
| Chief Product & Growth Officer | no data | no data | no data | |
| Chief Privacy & Regulatory Officer | no data | no data | no data |
Experienced Management: U76's management team is considered experienced (4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 14.7yrs | US$1.19m | 1.5% € 14.0m | |
| Independent Director | 12.9yrs | no data | no data | |
| Independent Chairperson & Lead Director | 6.7yrs | US$218.04k | 0% € 0 | |
| Independent Director | 4.8yrs | US$93.82k | 0.19% € 1.8m | |
| Independent Director | 1.5yrs | US$476.17k | 0% € 0 | |
| Member of Clinical Advisory Board | less than a year | no data | no data | |
| Independent Director | 1.3yrs | US$473.11k | 0% € 0 | |
| Member of Clinical Advisory Board | less than a year | no data | no data | |
| Independent Director | 1.5yrs | US$490.98k | 0% € 0 | |
| Independent Director | 1.5yrs | US$481.61k | 0% € 0 | |
| Member of Clinical Advisory Board | less than a year | no data | no data | |
| Member of Clinical Advisory Board | less than a year | no data | no data |
Experienced Board: U76's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/01 20:00 |
| End of Day Share Price | 2025/11/28 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Omada Health, Inc. is covered by 12 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Vikram Kesavabhotla | Baird |
| Saket Kalia | Barclays |
| Sean Dodge | BMO Capital Markets Equity Research |